Innate Immune Induction and Influenza Protection Elicited by a Response-Selective Agonist of Human C5a

CCR2+ Monocyte-Derived Dendritic Cells and Exudate Macrophages Produce Influenza-Induced Pulmonary Immune Pathology and Mortality

(2014) K. L. Lin et al.   JOURNAL OF IMMUNOLOGY

GM-CSF in the Lung Protects against Lethal Influenza Infection

(2011) Fang-Fang Huang et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Innate Immunity in the Respiratory Epithelium

(2011) Dane Parker et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Control of methicillin resistant Staphylococcus aureus infection utilizing a novel immunostimulatory peptide

(2011) Tamsin R. Sheen et al.   VACCINE

The Influenza Virus Protein PB1-F2 Inhibits the Induction of Type I Interferon at the Level of the MAVS Adaptor Protein

(2011) Zsuzsanna T. Varga et al.   PLoS Pathogens

Respiratory epithelial cells in innate immunity to influenza virus infection

(2010) Catherine J. Sanders et al.   CELL AND TISSUE RESEARCH

Neutrophils: Cinderella of innate immune system

(2010) V. Kumar et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

The PB2 Subunit of the Influenza Virus RNA Polymerase Affects Virulence by Interacting with the Mitochondrial Antiviral Signaling Protein and Inhibiting Expression of Beta Interferon

(2010) K. M. Graef et al.   JOURNAL OF VIROLOGY

A novel adjuvant for vaccine development in the aged

(2010) Edward L. Morgan et al.   VACCINE

Single-Step Conjugation of Bioactive Peptides to Proteins via a Self-Contained Succinimidyl Bis-Arylhydrazone

(2009) Joy A. Phillips et al.   BIOCONJUGATE CHEMISTRY

Natural killer cells in infection and inflammation of the lung

(2009) Fiona J. Culley   IMMUNOLOGY

Complement component 5a (C5a)

(2009) Helga D. Manthey et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice

(2009) Arash Shahangian et al.   JOURNAL OF CLINICAL INVESTIGATION

Enhancement of in vivo and in vitro immune functions by a conformationally biased, response-selective agonist of human C5a: Implications for a novel adjuvant in vaccine design

(2009) Edward L. Morgan et al.   VACCINE

Immune responses to methamphetamine by active immunization with peptide-based, molecular adjuvant-containing vaccines

(2009) Michael J. Duryee et al.   VACCINE

Immunity to Respiratory Viruses

(2008) Jacob E. Kohlmeier et al.   Annual Review of Immunology

Animal models in influenza vaccine testing

(2008) Jan Willem van der Laan et al.   Expert Review of Vaccines

Locally Produced Complement Fragments C5a and C3a Provide Both Costimulatory and Survival Signals to Naive CD4+ T Cells

(2008) Michael G. Strainic et al.   IMMUNITY

A conformationally-biased, response-selective agonist of C5a acts as a molecular adjuvant by modulating antigen processing and presentation activities of human dendritic cells

(2008) Ganapati V. Hegde et al.   INTERNATIONAL IMMUNOPHARMACOLOGY